JP2006514638A5 - - Google Patents

Download PDF

Info

Publication number
JP2006514638A5
JP2006514638A5 JP2004558826A JP2004558826A JP2006514638A5 JP 2006514638 A5 JP2006514638 A5 JP 2006514638A5 JP 2004558826 A JP2004558826 A JP 2004558826A JP 2004558826 A JP2004558826 A JP 2004558826A JP 2006514638 A5 JP2006514638 A5 JP 2006514638A5
Authority
JP
Japan
Prior art keywords
pain
pharmaceutical composition
composition according
spongosine
dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004558826A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006514638A (ja
JP4836454B2 (ja
Filing date
Publication date
Priority claimed from GBGB0228723.3A external-priority patent/GB0228723D0/en
Application filed filed Critical
Publication of JP2006514638A publication Critical patent/JP2006514638A/ja
Publication of JP2006514638A5 publication Critical patent/JP2006514638A5/ja
Application granted granted Critical
Publication of JP4836454B2 publication Critical patent/JP4836454B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004558826A 2002-12-09 2003-12-09 疼痛、特に痛覚過敏治療のための、スポンゴシン(2−メトキシアデノシン)の使用。 Expired - Fee Related JP4836454B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0228723.3A GB0228723D0 (en) 2002-12-09 2002-12-09 Treatment of pain
GB0228723.3 2002-12-09
PCT/GB2003/005379 WO2004052377A1 (en) 2002-12-09 2003-12-09 Use of spongosine (2-methoxyadenosein) for the treatment of pain, in particular hyperalgesia

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010270287A Division JP2011132229A (ja) 2002-12-09 2010-12-03 疼痛、特に痛覚過敏治療のための、スポンゴシン(2−メトキシアデノシン)の使用。

Publications (3)

Publication Number Publication Date
JP2006514638A JP2006514638A (ja) 2006-05-11
JP2006514638A5 true JP2006514638A5 (cg-RX-API-DMAC7.html) 2006-12-07
JP4836454B2 JP4836454B2 (ja) 2011-12-14

Family

ID=9949371

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004558826A Expired - Fee Related JP4836454B2 (ja) 2002-12-09 2003-12-09 疼痛、特に痛覚過敏治療のための、スポンゴシン(2−メトキシアデノシン)の使用。
JP2010270287A Withdrawn JP2011132229A (ja) 2002-12-09 2010-12-03 疼痛、特に痛覚過敏治療のための、スポンゴシン(2−メトキシアデノシン)の使用。

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010270287A Withdrawn JP2011132229A (ja) 2002-12-09 2010-12-03 疼痛、特に痛覚過敏治療のための、スポンゴシン(2−メトキシアデノシン)の使用。

Country Status (18)

Country Link
US (2) US8252766B2 (cg-RX-API-DMAC7.html)
EP (1) EP1581235B1 (cg-RX-API-DMAC7.html)
JP (2) JP4836454B2 (cg-RX-API-DMAC7.html)
KR (1) KR101122495B1 (cg-RX-API-DMAC7.html)
CN (2) CN100471503C (cg-RX-API-DMAC7.html)
AT (1) ATE430572T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003288451B2 (cg-RX-API-DMAC7.html)
CA (1) CA2507918A1 (cg-RX-API-DMAC7.html)
CY (1) CY1109229T1 (cg-RX-API-DMAC7.html)
DE (1) DE60327557D1 (cg-RX-API-DMAC7.html)
DK (1) DK1581235T3 (cg-RX-API-DMAC7.html)
ES (1) ES2326532T3 (cg-RX-API-DMAC7.html)
GB (2) GB0228723D0 (cg-RX-API-DMAC7.html)
NO (1) NO20053042L (cg-RX-API-DMAC7.html)
NZ (1) NZ540353A (cg-RX-API-DMAC7.html)
PT (1) PT1581235E (cg-RX-API-DMAC7.html)
SI (1) SI1581235T1 (cg-RX-API-DMAC7.html)
WO (1) WO2004052377A1 (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0228723D0 (en) 2002-12-09 2003-01-15 Cambridge Biotechnology Ltd Treatment of pain
GB0305149D0 (en) * 2003-03-07 2003-04-09 Cambridge Biotechnology Ltd Compounds for the treatment of pain
KR20070004792A (ko) * 2004-03-05 2007-01-09 캠브리지 바이오테크놀로지 리미티드 아데노신 수용체 작용제
PE20060272A1 (es) 2004-05-24 2006-05-22 Glaxo Group Ltd (2r,3r,4s,5r,2'r,3'r,4's,5's)-2,2'-{trans-1,4-ciclohexanodiilbis-[imino(2-{[2-(1-metil-1h-imidazol-4-il)etil]amino}-9h-purin-6,9-diil)]}bis[5-(2-etil-2h-tetrazol-5-il)tetrahidro-3,4-furanodiol] como agonista a2a
GB0426394D0 (en) * 2004-12-01 2005-01-05 Health Prot Agency Fusion proteins
US8778634B2 (en) 2004-12-01 2014-07-15 Syntaxin, Ltd. Non-cytotoxic protein conjugates
US8399400B2 (en) * 2004-12-01 2013-03-19 Syntaxin, Ltd. Fusion proteins
US8603779B2 (en) 2004-12-01 2013-12-10 Syntaxin, Ltd. Non-cytotoxic protein conjugates
US8512984B2 (en) 2004-12-01 2013-08-20 Syntaxin, Ltd. Non-cytotoxic protein conjugates
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
GB0610867D0 (en) * 2006-06-01 2006-07-12 Syntaxin Ltd Treatment of pain
CN101479268B (zh) 2006-06-27 2012-08-08 Cbt发展有限公司 2-0’-甲基腺苷衍生物及其用作制备腺苷受体的激动剂或拮抗剂的应用
NZ573308A (en) * 2006-06-27 2012-02-24 Biovitrum Ab Publ Adenosine derivatives for the treatment of pain
US7906518B2 (en) 2006-06-27 2011-03-15 Cbt Development Limited Therapeutic compounds
CN101938904A (zh) * 2008-01-09 2011-01-05 PGx健康有限责任公司 用a2ar激动剂鞘内治疗神经性疼痛
US8221791B1 (en) 2008-12-10 2012-07-17 University Of Central Florida Research Foundation, Inc. Silica-based antibacterial and antifungal nanoformulation
EP2451456A1 (en) * 2009-07-09 2012-05-16 CBT Development Limited Combined preparation for use as a medicament
US20130123208A1 (en) * 2010-05-12 2013-05-16 The Regents of the University of Colorado, a body corporation Method of treating multiple sclerosis with adenosine receptor agonists
EP2631345B1 (en) * 2012-02-27 2019-09-04 Electrolux Home Products Corporation N.V. Washing tub unit and washing machine
US20140056870A1 (en) 2012-08-27 2014-02-27 Allergan, Inc. Fusion proteins
US11066416B2 (en) 2016-02-04 2021-07-20 The Johns Hopkins University Rapafucin derivative compounds and methods of use thereof
AU2017214557B2 (en) * 2016-02-04 2022-05-19 The Johns Hopkins University Rapadocins, inhibitors of equilibrative nucleoside transporter 1 and uses thereof

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE792155A (fr) 1971-12-01 1973-05-30 Takeda Chemical Industries Ltd Nouveaux derives de l'adenosine et leur procede de production
JPS4861498A (cg-RX-API-DMAC7.html) 1971-12-01 1973-08-28
DE2359536C2 (de) * 1972-12-08 1984-08-02 Takeda Chemical Industries, Ltd., Osaka 2,6-Diaminonebularinderivate
JPS5549594B2 (cg-RX-API-DMAC7.html) 1972-12-08 1980-12-12
JPS5461195A (en) * 1977-10-21 1979-05-17 Takeda Chem Ind Ltd N2-substituted phenyl-2,6-diaminonebularin
JPS5461194A (en) 1977-10-21 1979-05-17 Takeda Chem Ind Ltd Preparation of n22substituted 2*66diaminonebularin
US4705758A (en) * 1984-06-19 1987-11-10 Warner-Lambert Company Adenosine receptor assay and kit
US5231086A (en) * 1985-09-24 1993-07-27 Item Development Aktiebolag Continuous administration adenosine to increase myocardial blood flow
US5104859A (en) * 1985-09-24 1992-04-14 Solimedco Aktiebolag Continuous administration of adenosine to reduce pulmonary vascular resistance
US5310732A (en) * 1986-02-03 1994-05-10 The Scripps Research Institute 2-halo-2'-deoxyadenosines in the treatment of rheumatoid arthritis
US5140015A (en) 1990-02-20 1992-08-18 Whitby Research, Inc. 2-aralkoxy and 2-alkoxy adenosine derivatives as coronary vasodilators and antihypertensive agents
US5679650A (en) * 1993-11-24 1997-10-21 Fukunaga; Atsuo F. Pharmaceutical compositions including mixtures of an adenosine compound and a catecholamine
US5677290A (en) * 1990-05-10 1997-10-14 Fukunaga; Atsuo F. Therapeutic use of adenosine compounds as surgical anesthetics
US6180616B1 (en) * 1990-05-10 2001-01-30 Atsuo F. Fukunaga Use of purine receptor agonists to alleviate or normalize physiopathologically excited sensory nerve function
US6004945A (en) * 1990-05-10 1999-12-21 Fukunaga; Atsuo F. Use of adenosine compounds to relieve pain
WO1994023723A1 (en) 1993-04-15 1994-10-27 New York University Adenosine receptor agonists for the promotion of wound healing
US5683989A (en) * 1993-12-17 1997-11-04 Novo Nordisk A/S Treatment of ischemias by administration of 2,N6 -substituted adenosines
SE9401499D0 (sv) 1994-05-02 1994-05-02 Item Dev Ab New method of treatment
PL316985A1 (en) 1994-05-10 1997-03-03 Sandoz Ltd Derivatives of adenosine
US5596094A (en) * 1994-05-26 1997-01-21 Sandoz Ltd. Process for preparing 2' -0- alkyl adenosine derivatives
US5877180A (en) * 1994-07-11 1999-03-02 University Of Virginia Patent Foundation Method for treating inflammatory diseases with A2a adenosine receptor agonists
IT1275420B (it) 1995-06-02 1997-08-05 Schering Plough S P A Metodo per misurare l'affinita' di legame al recettore a2a dell'adenosina di componenti di interesse farmacologico mediante l'uso del ligando triziato (3h)-sch 58261
WO1998052611A1 (en) 1997-05-23 1998-11-26 Nippon Shinyaku Co., Ltd. Medicinal composition for prevention or treatment of hepatopathy
US6110902A (en) * 1997-06-23 2000-08-29 Moehler; Hanns Method for the inhibition of neuronal activity leading to a focal epileptic seizure by local delivery of adenosine
CA2296485A1 (en) 1997-07-29 1999-02-11 Medco Research, Inc. N6-substituted-adenosine-5'-uronamides as adenosine receptor modulators
US6440455B1 (en) 1997-09-02 2002-08-27 Children's Medical Center Corporation Methods for modulating the axonal outgrowth of central nervous system neurons
GB9723590D0 (en) * 1997-11-08 1998-01-07 Glaxo Group Ltd Chemical compounds
JP2002500188A (ja) 1998-01-08 2002-01-08 ザ・ユニバーシティ・オブ・バージニア・パテント・ファウンデーション A2aアデノシンレセプター作動因子
GB9913932D0 (en) 1999-06-15 1999-08-18 Pfizer Ltd Purine derivatives
US20030008841A1 (en) 2000-08-30 2003-01-09 Rene Devos Anti-HCV nucleoside derivatives
GB0228723D0 (en) 2002-12-09 2003-01-15 Cambridge Biotechnology Ltd Treatment of pain
CA2551169A1 (en) 2002-12-23 2004-07-08 Global Cardiac Solutions Pty Ltd Organ preconditioning, arrest, protection, preservation and recovery
GB0305153D0 (en) 2003-03-07 2003-04-09 Cambridge Biotechnology Ltd Identification of therapeutic compounds
GB0305149D0 (en) 2003-03-07 2003-04-09 Cambridge Biotechnology Ltd Compounds for the treatment of pain
GB0305150D0 (en) * 2003-03-07 2003-04-09 Cambridge Biotechnology Ltd Use of therapeutic compounds
KR20070004792A (ko) 2004-03-05 2007-01-09 캠브리지 바이오테크놀로지 리미티드 아데노신 수용체 작용제
US8407664B2 (en) 2005-12-30 2013-03-26 Sap Ag Software model business objects

Similar Documents

Publication Publication Date Title
JP2011132229A5 (cg-RX-API-DMAC7.html)
JP4836454B2 (ja) 疼痛、特に痛覚過敏治療のための、スポンゴシン(2−メトキシアデノシン)の使用。
JP2006519823A5 (cg-RX-API-DMAC7.html)
KR20190125537A (ko) 톨-유사 수용체 조정제의 고체 형태
EP2277512A3 (en) Pharmaceutical compositions and dosage forms of thalidomide
MX2022013753A (es) Tratamiento de enfermedades respiratorias con compuestos de aminoacidos.
CY1109629T1 (el) Συνθεσεις ρυθμιστη υποδοχεα 5ht2c και μεθοδοι χρησης
ES2797900T3 (es) Compuestos y combinaciones para el tratamiento del VIH
CN100579533C (zh) 治疗疼痛的化合物
JP2023526304A (ja) コロナウイルス感染症治療のためのtlr7/8拮抗薬
RU2441875C2 (ru) Терапевтические соединения
WO2018217139A4 (ru) Новые ингибиторы глутаминилциклаз и их применение для лечения различных заболеваний
US11452747B2 (en) Compositions of oligofructose and commensal microorganisms and methods thereof
Cheema et al. Efficacy and safety of favipiravir for the treatment of COVID-19 outpatients: a systematic review and meta-analysis of randomized controlled trials
RU2012115450A (ru) Применение антагонистов опиоидных рецепторов при заболеваниях желудочно-кишечного тракта
JP5123574B2 (ja) ヒアルロン酸生成増強剤
RU2009102536A (ru) Терапевтические соединения
Zhang et al. UTL-5g Lowers Elevated Blood Levels of TNF-α and TGF-β and Increases Survival Rates in Animals Treated with LPS/D-(+)-galactosamine
HK1086186B (en) Use of spongosine (2-methoxyadenosein) for preparing pharmaceutical for the treatment of pain
RU2025124512A (ru) Смесь неперевариваемых олигосахаридов
MX2024008662A (es) Compuestos de pirrolo[1,2-b]-2-piridazinona como agonistas del receptor de 5-hidroxitriptamina 4 (5-ht4).
Bascom Stimulant-induced pulmonary toxicity. Chest 108
JPWO2017126648A1 (ja) N−[7−[(メチルスルホニル)アミノ]−4−オキソ−6−フェノキシ−4h−1−ベンゾピラン−3−イル]ホルムアミドまたはその塩を含有する医薬組成物
SHINAGAWA et al. ANTIBIOTIC PROPHYLAXIS IN ELECTIVE UPPER GASTROINTESTINAL SURGERY COMPARISON OF CEFTIZOXIME AND PIPERACILLIN
HK1087629B (en) Compounds for the treatment of pain